— Know what they know.
Not Investment Advice

ARVN NASDAQ

Arvinas, Inc.
1W: -3.4% 1M: -14.4% 3M: -24.1% YTD: -20.7% 1Y: +37.0% 3Y: -61.0% 5Y: -86.4%
$9.09
-0.01 (-0.11%)
 
Weekly Expected Move ±6.0%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 29 · $586.5M mcap · 56M float · 1.65% daily turnover · Short 38% of daily vol

Balance Sheet Trends

Total Assets
$718M -34.2% ▼
5Y CAGR: +0.0%
Total Liabilities
$284M -46.4% ▼
5Y CAGR: +30.4%
Shareholders Equity
$434M -22.8% ▼
5Y CAGR: -7.5%
Cash & Investments
$685M -34.1% ▼
5Y CAGR: -0.1%
Total Debt
$8M -12.4% ▼
5Y CAGR: +15.7%
Net Debt
-$134M -48.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$108M$81M$312M$100M$143M
Short-Term Investments$1.4B$1.1B$949M$939M$542M
Cash & ST Investments$1.5B$1.2B$1.3B$1.0B$685M
Net Receivables$26M$8M$7M$14M$6M
Inventory$0$0$0$0$0
Other Current Assets$4M$27M$12M$14M$9M
Total Current Assets$1.6B$1.2B$1.3B$1.1B$701M
Property, Plant & Equip.$17M$18M$14M$16M$13M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$12M$11M$10M$8M$4M
Total Non-Current Assets$29M$29M$24M$24M$17M
Total Assets$1.6B$1.3B$1.3B$1.1B$718M
— Liabilities —
Accounts Payable$31M$6M$18M$13M$24M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$206M$219M$163M$156M$71M
Other Current Liabilities$12M$19M$48M$0$40M
Total Current Liabilities$262M$295M$257M$230M$142M
Long-Term Debt$1M$1M$800K$600K$400K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$538M$409M$388M$300M$142M
Total Liabilities$800M$704M$645M$530M$284M
— Equity —
Common Stock$0$100K$100K$100K$100K
Retained Earnings-$683M-$965M-$1.3B-$1.5B-$1.6B
Accumulated OCI-$5M-$19M-$3M$1M$1M
Total Stockholders Equity$782M$565M$660M$562M$434M
Total Liabilities & Equity$1.6B$1.3B$1.3B$1.1B$718M
— Key Metrics —
Total Debt$5M$6M$3M$10M$8M
Net Debt-$103M-$76M-$308M-$91M-$134M
Total Investments$1.4B$1.1B$949M$939M$542M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms